NCT07507669

Impact of MetaCalm on Stress of Healthy People With Acute Stress

Evaluation of MetaCalm at Two Dose Levels in Healthy Adults With Acute Stress: An Open-Label, Non-Randomized Clinical Study

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 280 (estimated)
• Sponsor: Metagenics, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This Open-Label, Non-Randomized Clinical Study involving 280 participants who will undergo a total participation of 6 hours.

Detailed description

The trial begins with a screening process to assess eligibility for the study. Participants will then receive 2 or 4 MetaCalm chewable tablets, followed by a 6-hour phase during which they will be asked to complete several questionnaires at different times after taking the tablets.

Conditions

• Adults
• Acute Stress Reaction

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	2 chewable tablets of MetaCalm	2 chewable tablets is administered orally at time T0 (during an episode of acute stress).
DIETARY_SUPPLEMENT	4 chewable tablets of MetaCalm	4 chewable tablets is administered orally at time T0 (during an episode of acute stress).

Timeline

• Start date: 2026-04-15
• Primary completion: 2026-06-30
• Completion: 2026-08-31
• First posted: 2026-04-02
• Last updated: 2026-04-13

Locations

1 site across 1 country: Italy